Litcius/Paper detail

<i>Notes from the Field:</i> Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 — New York City, November 1, 2022–January 4, 2023

Elizabeth Luoma, Rebecca Rohrer, Hilary Parton, Scott Hughes, Enoma Omoregie, Faten Taki, Jade Wang, Saymon Akther, Helly Amin, Carolyn Chang, Iris Cheng, Steve Di Lonardo, Meredith Eddy, Lauren Firestein, Wenhui Li, Michelle Su, Ellen H. Lee

2023MMWR Morbidity and Mortality Weekly Report15 citationsDOIOpen Access PDF

Abstract

Bivalent booster vaccination data were

Topics & Concepts

MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyRecombinant DNAGerontologyInternal medicineOutbreakGeneticsInfectious disease (medical specialty)GeneBiologyDiseaseCOVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research
<i>Notes from the Field:</i> Epidemiologic Characteristics of SARS-CoV-2 Recombinant Variant XBB.1.5 — New York City, November 1, 2022–January 4, 2023 | Litcius